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Summary 
Background and aims. Cerebral bypasses are categorized according to function (flow-
augmentation vs flow-preservation), and to characteristics: direct vs indirect vs combined bypass, 
extra-to-intracranial vs intra-to-intracranial bypass, high- vs moderate- vs low-capacity bypass. We 
critically summarize the current state of evidence and grades of recommendation for cerebral 
bypass surgery. 
Methods. The current indications for cerebral bypass are discussed depending on the function of 
the bypass (flow-preservation vs -augmentation) and analyzed according to level of evidence 
criteria. 
Results. Flow-preservation bypass plays an important role for managing complex intracranial 
aneurysms (level of evidence 4; grade of recommendation C). Flow-preservation bypass is 
currently only very rarely indicated in the treatment of cerebral tumors involving major cerebral 
arteries (level of evidence 5 – grade of recommendation D): the trend has evolved in favor of 
partial resection and radiotherapy. To preserve the flow, the bypass is always a direct bypass.  
Flow-augmentation bypass is currently recommended for Moyamoya patients with ischemic 
symptoms and compromised hemodynamics (level of evidence 4; grade of recommendation C) 
and Moyamoya patients with hemorrhagic onset (level of evidence 1B - grade of recommendation 
A). Flow-augmentation bypass is currently not recommended for patients with recently 
symptomatic carotid artery occlusion even in the setting of compromised cerebral hemodynamics 
(level of evidence 1A - grade of recommendation A), but may be considered for patients with 
hemodynamic failure and recurrent medically refractory symptoms as a final resort (level of 
evidence 5 – grade of recommendation D) 
Conclusions: The results of recent RCTs narrow the indication for cerebral bypass in the setting 
of ischemic cerebrovascular disease. However cerebral bypass is still very useful for managing 
complex intracranial aneurysms (not amenable to selective clipping or endovascular therapies) and 
the only treating option for managing symptomatic patients with Moyamoya vasculopathy and 
impaired brain hemodynamics. 
 
Keywords: cerebral bypass, cerebral revascularization, evidence-based medicine, grades of 
recommendation, indications, level of evidence. 	
Background  
In the current neurosurgical practice different types of bypasses can be distinguished. According to 
their function, cerebral bypasses can be classified into “flow-augmentation” and “flow-
preservation”.[8, 12]  
The aim of a flow-augmentation bypass is to restore blood flow to a hypoperfused brain territory in 
order to avoid stroke in patients with symptomatic steno-occlusive diseases of major cerebral 
arteries.[12, 16]  
The aim of a flow-preservation bypass is to replace blood flow to a brain territory previously 
perfused via a major vessel, the sacrifice of which is necessary to treat an underlying disease 
(such as an aneurysm). [12, 14, 38] 	
Bypass surgery is categorized into direct, indirect and combined procedures. A direct bypass 
consists of a direct microvascular anastomosis between a donor artery (for instance the superficial 
temporal artery – STA) and an intracranial recipient artery, and instantly delivers blood flow to the 
brain. [6, 12, 14, 16, 28] Depending on the choice of the donor artery, direct bypass is classified 
asextra-to-intracranial (EC-IC) vs. intra-to-intracranial (IC-IC). Furthermore, the donor and the 
recipient artery can be anastomosed with vs. without graft interposition, depending on the 
interposition or not of a vascular graft (arterial or venous).[12] The bypass is traditionally named 
according to the donor and the recipient vessels (i.e.: superficial temporal artery to middle cerebral 
artery - STA-MCA - bypass).[9, 12, 14] Direct bypass procedures can be further  categorized 
according to the amount of flow (capacity) provided: low (<50 ml/min) vs. intermediate (50-100 
ml/min) vs. high-capacity (>100ml/min).[12, 38] It is important to match the flow to demand i.e. the 
bypass must supply adequate flow  for the needs of the vascular territory that is revascularized.  
Indirect bypasses rely on the overlay of vascularized tissue (i.e.: muscle, dura, pericranium, 
omentum) onto the cerebral cortex. The aim is to promote neoangiogenesis over time and achieve  
delayed revascularization. [12, 15, 27, 28]  
Combined bypass consists of the “combination” of direct and indirect bypass in the same surgical 
session.[12, 16] 
To preserve  flow, the bypass must be a direct bypass, and needs to be performed before 
permanent occlusion of the vessel. To augment flow, direct, indirect and combined techniques can 
be applied. 
Herein we summarize the current state of evidence and discuss the grades of recommendation for 
cerebral bypass surgery, using the “Oxford Centre for Evidence-Based Medicine (OCEBM) Levels 
of Evidence” for grading levels of evidence and recommendations (http://www.cebm.net). 
 
Flow-preservation bypass  
Bypass surgery plays an important role in managing complex intracranial aneurysms not amenable 
to endovascular therapy or selective clip reconstruction. [14]Treatment of such lesions may in fact 
require vessel occlusion or “trapping”, which involves sacrifice of the arery bearing the aneurysm 
and/or efferent arteries.[12, 14, 17] The goal of any aneurysm treatment is however both aneurysm 
exclusion and preservation of blood flow to the brain. Therefore, bypass is essential to replace the 
flow provided by the sacrificed artery.[14, 17] In flow-preservation bypass surgery, a key point is 
that the bypass has to match the flow of the sacrificed artery: intraoperative quantitative flow 
measurements allow confirmation of flow-matching. [3, 12, 14] 
The type of bypass performed in this setting is always a direct bypass, in order to deliver the flow 
instantly to the involved territory. By varying the bypass construct (end-to-side vs end-to-end vs 
side-to-side anastomosis; single vs double bypass) the bypass can be customized to the 
intracranial angioanatomy. [11, 12, 14, 17, 26, 38] Complex aneurysms are rare lesions and their 
variety and heterogeneity do not lend themselves to  RCTs. [12] The utility of  bypass for managing 
complex intracranial aneurysms has been demonstrated  primarily by   case series (level of 
evidence 4, grade of recommendation C – see table 2). [7, 14, 26, 38] 
Radical removal of cerebral tumors involving the proximal brain vasculature can be impossible 
without sacrificing a major artery and replacing it with a bypass.[5, 12] The risk-benefit ratio for 
complete tumor resection combined with a bypass versus partial resection has evolved towards 
partial resection and adjuvant therapy (radio- or chemotherapy).[5, 12, 21] Flow-preservation 
bypass for tumors has substantially declined in frequency during the last decades.  Bypass surgery 
can be considered only in very selected cases, and has to be balanced against whether the benefit 
of radical resection plus arterial sacrifice and bypass outweighs the risks in terms of improving 
survival with good quality of life. Cerebral tumors involving the proximal brain vasculature (i.e.: 
skull base tumors) are also a rare disease: the variety and heterogeneity of these lesions preclude 
RCTs. Only few case series, and expert opinion, are available (level of evidence 5, grade of 
recommendation D – see table 2). [7, 12, 22, 41]  
 
 Flow-augmentation bypass  
Bypass surgery is the only effective treatment for managing patients with symptomatic Moyamoya 
vasculopathy and impaired brain hemodynamics. Bypass surgery has been shown to decrease 
both ischemic and haemorrhagic stroke rates [12, 16, 27, 32].  
Direct, indirect and combined bypass procedures are used for treating Moyamoya.[27, 37] There is 
no definitive consensus on which procedure is superior.[15, 27] Traditionally, direct or combined 
bypass is used in adults, while indirect or combined bypass are applied in children.[12, 27, 37] . 
The most common direct bypass is the STA–MCA bypass.[12, 16, 37]  Among the indirect 
techniques, the following can be considered: encephalo-myo-synangiosis (EMS) [12, 16], 
encephalo-duro-myo-synangiosis (EDMS) [16], encephalo-arterio-synangiosis (EAS)[24], 
encephalo-myo-arterio-synangiosis (EMAS)[31], encephalo-duro-arterio-myo-synangiosis 
(EDAMS)[25], encephalo-duro-arterio-synangiosis (EDAS)[40], encephalo-duro-periosteal-
synangiosis (EDPS)[16] , multiple burr-holes[23], omental transplantation[42]. 
Combined bypass offers the advantages of direct and indirect methods. However, the procedures 
are somewhat more complex and  time-consuming.[12, 16, 27]  
There are no RCTs which have studied the value of bypass surgery for prevention of ischemic 
stroke and cognitive deterioration in Moyamoya patients. However, there are a number of   
observational studies which strongly indicate that bypass benefits these patients [27, 36, 39] 
compared to natural history; there is an unfavorable annual ischemic stroke rate in untreated 
patients (up to 13.3%)[19] and a high rate of disease progression with subsequent symptom 
occurrence in non surgically treated hemispheres[12, 29].  In light of existing data, an RCT to test 
bypass surgery efficacy for prevention of ischemic stroke recurrence and cognitive deterioration in 
symptomatic Moyamoya patients is unlikely be performed. [12, 27, 36, 39] due to a lack of 
equipoise.  Based on existing observational studies, surgery is  routinely recommended for 
children and adults with ischemic symptoms and compromised hemodynamics (level of evidence 
4; grade of recommendation C – see table 2).[7, 12, 16, 27, 34, 36, 39]  
As for hemorrhagic moyamoya disease, bypass surgery has RCT evidence demonstrating its 
efficacy in preventing recurrence of hemorrhagic stroke in patients with Moyamoya Diseases 
(MMD)    ,[32]. Although statistically marginal, the Japanese Adult Moyamoya (JAM)Trial   showed 
that direct (or combined) bypass surgery for adult patients with haemorrhagic-MMD reduces the re-
bleeding rate and improves patient prognosis during the 5 years following enrolment (level of 
evidence 1B - grade of recommendation A) (See table 2).[7, 32] Bypass is thought to improve 
cerebral hemodynamics, and reduce the hemodynamic stress on  the rupture-prone fragile 
Moyamoya collateral vessels.[32]  
 
The topic of flow-augmentation bypass in patients with symptomatic cerebrovascular 
atherosclerotic occlusion of   extracranial   or intracranial major arterieshas been extensively 
debated in the past. [1, 13, 33] The main question has been:whether STA-MCA bypass (plus 
medical therapy) benefit patients with symptomatic cerebrovascular atherosclerotic occlusion in 
comparison to medical therapy.  
To answer this question, RCTs have been conducted. The ”EC-IC Bypass Trial” [1], the first 
prospective RCT in these field published in 1985, showed no significant advantage of bypass 
surgery in reducing the incidence of fatal and nonfatal ischemic strokes.[1, 35] This study was hotly 
debated: [4] among the various criticisms, the most important was related to the lack of 
hemodynamic criteria used to identify and select high-risk patients who might benefit from 
bypass.[12] 
A Cochrane review[18], published in 2010, reported the results of 21 trials (two randomized and 19 
non-randomized studies) for patients with symptomatic carotid occlusion. Bypass was shown to be 
neither superior nor inferior to medical care alone.[12, 18]  
The “Carotid Occlusion Surgery Study (COSS)” [33] is a RCT whose results were published in 
2011. In this study patients were selected based on very strict hemodynamic criteria, to identify 
those high-risk patients who might benefit most from bypass.[10, 20, 35]. However, STA-MCA 
bypass (plus medical therapy) was shown to provide no clinical benefit over medical therapy alone. 
[12, 33]. 
An ancillary study to COSS,, the “Randomized Evaluation of Carotid Occlusion and 
Neurocognition” (RECON) Trial [30] tested  neurocognition at 2 years in COSS patients.  . and was 
unable to identify a  benefit of bypass   when compared to medical therapy alone. [30].  
Both the EC-IC Bypass Trial and COSShave generated level I evidence indicating no benefit of 
bypass forpatients with recently symptomatic carotid artery occlusion (in comparison to medical 
therapy alone).[1, 33, 35] Bypass failed to show benefit both because medical therapy performed 
better than in the past and because of the  relatively high complication rate in the perioperative 
period,  (most of which was non-bypass related) potentially due to the fragility of these flow-
compromised patients. [12] Bypass is therefore currently not indicated for these patients (level of 
evidence 1A, grade of recommendation A) [7, 12, 30, 33].  
However, there are subcategories of patients, not included in these RCTs (EC-IC Bypass trial and 
COSS), for whom flow-augmentation bypass could still be of benefit and may be used as a last 
resort to avoid disabling stroke despite optimal medical and interventional management: [2, 12]  (1) 
patients presenting with ongoing hemodynamic symptoms (postural or with blood pressure 
variations); (2) patients having acute stroke with evidence of persistent oligemic brain tissue at risk 
of infarction (penumbra). 
Currently,  two other studies are underway. One, the “Carotid and Middle Cerebral Artery 
Occlusion Surgery Study” (CMOSS), in China (ClinicalTrials.gov NCT01758614), and the other, 
the “EDAS (Surgical) Revascularization in patients with Symptomatic Intracranial Arterial Stenosis 
(ERSIAS)”, in the USA. Both may give new insights into the role of direct and indirect bypass 
respectively (ClinicalTrials.gov NCT01819597). 
 
Conclusion 
Cerebral bypass still represents an important treatment option for managing specific 
cerebrovascular conditions.  
Flow-preservation bypass plays an important role for managing complex intracranial aneurysms 
(level of evidence 4; grade of recommendation C). Flow-preservation bypass is   only very rarely 
indicated in the treatment of cerebral tumors involving major arteries (level of evidence 5 – grade 
of recommendation D), where the trend has evolved in favor of partial resection and radiotherapy. 
To preserve  flow, the bypass is always a direct bypass.  
Flow-augmentation bypass is currently recommended for Moyamoya patients with ischemic 
symptoms and compromised hemodynamics (level of evidence 4; grade of recommendation C) 
and patients with Moyamoya disease with hemorrhagic onset (level of evidence 1B - grade of 
recommendation A). Flow-augmentation bypass is currently not recommended for patients with 
recently symptomatic carotid artery occlusion failure of cerebral hemodynamics (level of evidence 
1A - grade of recommendation A), but may be considered in select patients with refractory 
hemodynamic symptoms (level of evidence 5 – grade of recommendation D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BYPASS TYPES  
Function of bypass Flow-augmentation  
Flow-preservation 
Type of Direct bypass EC-IC No graft interposition 
revascularization bypass Graft interposition  
IC-IC 
bypass 
No graft interposition 
Graft Interposition 
Indirect bypass EMS 
EDMS 
EAS 
EMAS 
EDAMS 
EDAS 
EDPS 
Multiple burr-holes 
Omental transplantation 
Combined bypass Direct + indirect bypass procedures 
Characteristics of 
the anastomosis 
Type Occlusive (conventional) 
Non-Occlusive (ELANA) 
Anatomy End-to-side 
End-to-end 
Side-to-side 
Capacity Low (<50 ml/min)  
Intermediate (50-100 ml/min) 
High (>100 ml/min) 
Table 1: Bypass types. EAS: encephalo-arterio-synangiosis. EC-IC: extra-to-intracranial. EDAMS: 
encephalo-duro-arterio-myo-synangiosis. EDAS: encephalo-duro-arterio-synangiosis. EDMS: 
encephalo-duro-myo-synangiosis. EDPS: encephalo-duro-periosteal-synangiosis. ELANA: Excimer 
Laser Assisted Non-occlusive Anastomosis. EMAS: encephalo-myo-arterio-synangiosis. EMS: 
encephalo-myo-synangiosis. IC-IC: intra-to-intracranial. 
 
  
 
Bypass role Indication Bypass 
Indicated 
Level of 
evidence  
Grade of 
recommendation 
RCT 
FLOW-
PRESERVATION 
Complex 
Aneurysms* 
Yes 4 C N.A. 
Tumors Rarely 5 D N.A. 
 
 
 
FLOW 
AUGMENTATION 
Moya ischemic Yes 4 C / 
Moya 
hemorrhagic 
Yes 1B A Yes 
Symptomatic 
cerebrovascular 
atherosclerotic 
steno-occlusive 
disease 
No** 1A A Yes 
Table 2: Current indications for cerebral bypass: level of evidence (N.A.: not applicable). 
The “Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence” has been 
used for grading levels of evidence and recommendations (http://www.cebm.net). 
* Complex aneurysms not amenable to direct clipping or definitive endovascular therapy 
** may be indicated in select cases presenting with ongoing hemodynamic symptoms (postural or 
with blood pressure variations) despite maximal medical management or patients having acute 
stroke with evidence of persistent oligemic brain tissue at risk of infarction (penumbra). 
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